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Histiocytosis X (Langerhan’s cell granulomatosis)
is a disease of unknown aetiology, but viral origin has
been implicated.
1
It is a clinicopathologic entity
characterized by proliferation of Langerhan’s cell
(which are not primarily phagocytic) in an
appropriate milieu.
2
A 27-year-old man presented with a 6-year
history of painless progressive left forearm swelling.
There was no antecedent history of trauma or
surgical maneuvers. His past medical history was
insignificant. Clinical examination revealed a well
preserved young man with a non-tender globular
doughy left forearm swelling to the wrist level
measuring 16 × 18cm and stretched overlying skin
with prominent veins (Figure 1). The radial artery
pulsation was good. Skin sensation was also
preserved. Radiograph of the forearm (Figure 2)
showed lytic destruction of the ulnar bone and soft
tissue swelling. He had a packed cell volume of 37%.
Other blood parameters and chemistry were normal.
Tissue biopsy and histology showed diffuse sheets of
histiocytes having cleft nuclei and granular
eosinophilic cytoplasm invading into the skeletal
muscle and necrotic bone trabeculae (Figure 3). It
was diagnosed Histiocytosis X. Ablative surgery was
declined by the patient.
Figure 1. Forearm swelling Histiocytosis X
Figure 2. Histiocytes in skeletal muscle (H & E
x400)
Figure 3. Histiocytosis X bone
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Histiocytosis X has been grouped into many
clinical types (Table1) which overlap depending on
the age, organ (s) affectation and number of lesions
in any particular organ. It may present as a solitary
lesion or with multiple foci in an organ or as a
systemic disease with many organ affectation.
3
Several organs such as skin, bone, female genital
tract, lymph node, lung, thymus, stomach and central
nervous system have been implicated.
4
The
commonest site is the bone.
5
Pathologic staging of
the disease is divided into four groups (Table2).
Osteolytic lesions are uncommon except in the
mastoid region of the temporal bone.
6
Table 1. Simplified approach to types of
histiocytosis
1
1. Langerhan's cell disease
2. Xanthogranuloma family
3. Indeterminate cell histiocytosis
4. Sinus histiocytosis with massive
lymphadenopathy
Table2. Pathologic staging of langerhan’s cell diseases
1. Bone only or bone with involvements of first echelon lymph nodes ± contiguous soft tissue involvement
2. Skin and / or other squamous mucous membranes only or with involvement of related superficial lymph
nodes
3. Soft tissue and viscera only excluding above and multi-system disease. Specify tissue involved e.g., lung.
Lymph nodes, brain.
4. Multi-system disease with any combination of above. Specify each organ / tissue involved e.g., skin,
bone marrow, bone.
Definitive diagnosis of Histiocytosis X was based
on electron microscopic identification of Birbeck’s
cell or langerhan’s granule, which are elongated
zipper like cytoplasmic structures of indeterminate
fuction.
2
Diagnosis is also possible with light
microscopic examination of paraffin embedded tissue
as in this case, by the identification of mononuclear
cells (histiocytes) characterized by irregular,
elongated nuclei with prominent nuclear grooving
and folds and an eosinophilic cytoplasm.
1
Immunohistochemical identification of S – 100 and
CD1a antigen is also helpful.
1
Generally, this disease runs a benign course. In its
mildest form it is an eosinophilic granuloma and may
require only a biopsy for confirmation. Lesions which
are shown to invade surrounding skeletal muscles
exhibit the worst in terms of outcome and are shown
to cause multiple organ dysfunction.
7
Other
modalities of treatment for less aggressive form of
the disease include: curettage and bone grafting,
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